Multimorbidity cutoffa | Crude PR (95% CI) | Model 1b | Model 2c | Final Modeld | |
---|---|---|---|---|---|
PR (95% CI) | PR (95% CI) | PR (95% CI) | p Valuee | ||
 ≥ 2 morbidities |  |  |  |  |  |
 Mixed-race | 1.03 (1.01–1.06)** | 1.04 (1.01–1.06)** | 1.05 (1.03–1.08)*** | 1.06 (1.03–1.08)*** | 0.722 |
 Black | 1.09 (1.06–1.12)*** | 1.08 (1.05–1.11)*** | 1.10 (1.07–1.13)*** | 1.09 (1.06–1.12)*** |  |
 AIC | 17 173 | 17 068 | 16 566 | 16 454 |  |
 ≥ 3 morbidities |  |  |  |  |  |
 Mixed-race | 1.04 (1.00–1.08) | 1.04 (1.002–1.09)* | 1.08 (1.04–1.12)*** | 1.09 (1.04–1.13)*** | 0.282 |
 Black | 1.18 (1.13–1.23)*** | 1.16 (1.11–1.22)*** | 1.21 (1.15–1.26)*** | 1.19 (1.14–1.25)*** |  |
 AIC | 19 413 | 19 264 | 18 734 | 18 572 |  |
 ≥ 4 morbidities |  |  |  |  |  |
 Mixed-race | 1.06 (1.00–1.13) | 1.07 (1.003–1.14)* | 1.13 (1.06–1.21)*** | 1.14 (1.06–1.22)*** | 0.223 |
 Black | 1.31 (1.22–1.41)*** | 1.28 (1.20–1.38)*** | 1.37 (1.28–1.48)*** | 1.34 (1.25–1.44)*** |  |
 AIC | 16 006 | 15 836 | 15 417 | 15 231 |  |
 ≥ 5 morbidities |  |  |  |  |  |
 Mixed-race | 1.06 (0.95–1.17) | 1.07 (0.96–1.18) | 1.15 (1.04–1.28)** | 1.16 (1.04–1.28)** | 0.132 |
 Black | 1.37 (1.23–1.54)*** | 1.33 (1.19–1.49)*** | 1.46 (1.30–1.64)*** | 1.41 (1.26–1.59)*** |  |
 AIC | 10 510 | 10 401 | 10 079 | 9960 |  |
 ≥ 6 morbidities |  |  |  |  |  |
 Mixed-race | 1.15 (0.98–1.35) | 1.17 (0.99–1.37) | 1.27 (1.07–1.49)** | 1.27 (1.07–1.50)** | 0.921 |
 Black | 1.45 (1.21–1.74)*** | 1.39 (1.16–1.67)*** | 1.55 (1.29–1.86)*** | 1.47 (1.22–1.76)*** |  |
 AIC | 5793 | 5696 | 5580 | 5477 |  |